TV-46046

· Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TV-46046, covering 2022-01-26 to 2024-02-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age [Phase 1]

See pricing